Try our Advanced Search for more refined results

Boehringer Tries To Derail Mirapex Antitrust Suits

By Erin Fuchs ( December 21, 2009, 6:06 PM EST) -- Boehringer Ingelheim International GmbH has moved to dismiss two antitrust suits brought by rival Mylan Inc. and direct buyers that accuse the generics maker of knowingly prosecuting an invalid patent for Parkinson's drug Mirapex, arguing that the suits fail to meet pleading standards under Twombly....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Judge Analytics

powered by Lex Machina®

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!